Dazukibart is a humanized IgG1kappa anti-IFNB1 monoclonal antibody of murine origin, being investigated as a potential treatment for dermatomyositis, a complex autoimmune disorder pathologically characterized by the pronounced overexpression of interferon (IFN) inducible genes present within the blood, skin, and muscle tissue of affected patients.
Reinheit:
99.80%
CAS Nummer:
[2639474-65-8]
Target-Kategorie:
IFNAR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten